Research graph
References from Sarcopenia Is Associated With Severe Treatment Toxicity and Mortality in Older Adults With Advanced Cancer: A Secondary Analysis. Local targets link to admitted publications; unresolved targets remain external evidence.
Unresolved reference
2013 · External reference
Enrollment of Elderly Patients in Clinical Trials for Cancer Drug Registration: A 7‐Year Experience by the US Food and Drug Administration
10.1200/jco.2004.02.175 · 2004 · External reference
Older Adult Participation in Cancer Clinical Trials: A Systematic Review of Barriers and Interventions
2021 · External reference
Biological, Clinical, and Psychosocial Correlates at the Interface of Cancer and Aging Research
10.1093/jnci/djs145 · 2012 · External reference
Improving the Quality of Survivorship for Older Adults With Cancer
10.1002/cncr.30053 · 2016 · External reference
Sarcopenia: Revised European Consensus on Definition and Diagnosis
10.1093/ageing/afy169 · 2019 · External reference
Prevalence and Predictive Value of Pre‐Therapeutic Sarcopenia in Cancer Patients: A Systematic Review
10.1016/j.clnu.2017.07.010 · 2018 · External reference
The Decline in Skeletal Muscle Mass With Aging Is Mainly Attributed to a Reduction in Type II Muscle Fiber Size
10.1016/j.exger.2013.02.012 · 2013 · External reference
Neuromuscular Impairment at Different Stages of Human Sarcopenia
10.1002/jcsm.13531 · 2024 · External reference
The Response of Muscle Protein Anabolism to Combined Hyperaminoacidemia and Glucose‐Induced Hyperinsulinemia Is Impaired in the Elderly
2000 · External reference
Systematic Review and Meta‐Analysis of the Effects of Exercise in Older Adults With Sarcopenia
10.1038/s41598-026-55850-w · 2026 · External reference
Explore the Optimal Treatment Regimen Across Combinations of Variate Protein Sources and Exercise Modalities and Its Associated Factors in Older Adults: A Network Meta‐Analysis and Meta‐Regression of Randomized Controlled Trials
10.3390/nu18091409 · 2026 · External reference
The Effect of Oral Omega‐3 Polyunsaturated Fatty Acid Supplementation on Muscle Maintenance and Quality of Life in Patients With Cancer: A Systematic Review and Meta‐Analysis
10.1016/j.clnu.2021.04.031 · 2021 · External reference
Protein Intake, Weight Loss, Dietary Intervention, and Worsening of Quality of Life in Older Patients During Chemotherapy for Cancer
10.1007/s00520-020-05528-4 · 2021 · External reference
Re: What Nutritional Interventions Can Effectively Treat Sarcopenia in Older Adults With Cancer? A Systematic Review
10.1016/j.jgo.2026.102942 · 2026 · External reference
How Do We Define and Measure Sarcopenia? A Meta‐Analysis of Observational Studies
10.1093/ageing/afab148 · 2021 · External reference
Global Prevalence of Sarcopenia and Severe Sarcopenia: A Systematic Review and Meta‐Analysis
10.1002/jcsm.12783 · 2022 · External reference
Epidemiology of Sarcopenia: Prevalence, Risk Factors, and Consequences
10.1016/j.metabol.2023.155533 · 2023 · External reference
Research Priorities in Cancer Cachexia: The University of Rochester Cancer Center NCI Community Oncology Research Program Research Base Symposium on Cancer Cachexia and Sarcopenia
10.1097/spc.0000000000000301 · 2017 · External reference
Sarcopenia, Obesity, and Mortality in US Adults With and Without Chronic Kidney Disease
10.1016/j.ekir.2016.10.008 · 2017 · External reference
Physiological and Functional Failure in Chronic Obstructive Pulmonary Disease, Congestive Heart Failure and Cancer: A Debilitating Intersection of Sarcopenia, Cachexia and Breathlessness
10.1097/spc.0000000000000222 · 2016 · External reference
Influence of Adjuvant Therapy in Cancer Survivors on Endothelial Function and Skeletal Muscle Deoxygenation
10.1371/journal.pone.0147691 · 2016 · External reference
A Multifactorial Anti‐Cachectic Approach for Cancer Cachexia in a Rat Model Undergoing Chemotherapy
10.1002/jcsm.12035 · 2016 · External reference
Cancer and Chemotherapy Contribute to Muscle Loss by Activating Common Signaling Pathways
10.3389/fphys.2016.00472 · 2016 · External reference
Characterizing Cancer Cachexia in the Geriatric Oncology Population
10.1016/j.jgo.2018.08.008 · 2019 · External reference
The Loss of Skeletal Muscle Strength, Mass, and Quality in Older Adults: The Health, Aging and Body Composition Study
10.1093/gerona/61.10.1059 · 2006 · External reference
Putative Cut‐Points in Sarcopenia Components and Incident Adverse Health Outcomes: An SDOC Analysis
10.1111/jgs.16517 · 2020 · External reference
The FNIH Sarcopenia Project: Rationale, Study Description, Conference Recommendations, and Final Estimates
10.1093/gerona/glu010 · 2014 · External reference
Sarcopenia: An Undiagnosed Condition in Older Adults. Current Consensus Definition: Prevalence, Etiology, and Consequences. International Working Group on Sarcopenia
10.1016/j.jamda.2011.01.003 · 2011 · External reference
The Impact of Sarcopenia on Clinical Outcomes in Men With Metastatic Castrate‐Resistant Prostate Cancer
10.1371/journal.pone.0286381 · 2023 · External reference
Predicting Chemotherapy Toxicity in Older Adults With Cancer: A Prospective Multicenter Study
10.1200/jco.2011.34.7625 · 2011 · External reference
Evaluation of Geriatric Assessment and Management on the Toxic Effects of Cancer Treatment (GAP70+): A Cluster‐Randomised Study
10.1016/s0140-6736(21)01789-x · 2021 · External reference
Body Composition Assessment in Axial CT Images Using FEM‐Based Automatic Segmentation of Skeletal Muscle
10.1109/tmi.2015.2479252 · 2016 · External reference
Unresolved reference
External reference
Lower‐Extremity Function in Persons Over the Age of 70 Years as a Predictor of Subsequent Disability
10.1056/nejm199503023320902 · 1995 · External reference
Cancer Cachexia in the Age of Obesity: Skeletal Muscle Depletion Is a Powerful Prognostic Factor, Independent of Body Mass Index
10.1200/jco.2012.45.2722 · 2013 · External reference
Predicting the Probability for Falls in Community‐Dwelling Older Adults Using the Timed up & go Test
10.1093/ptj/80.9.896 · 2000 · External reference
Nonparametric‐Estimation From Incomplete Observations
10.1080/01621459.1958.10501452 · 1958 · External reference
Regression Models and Life‐Tables
10.1111/j.2517-6161.1972.tb00899.x · 1972 · External reference
Impact of Body Composition Changes on Treatment‐Related Toxicities and Clinical Outcomes in HER2‐Positive Metastatic Breast Cancer Patients Receiving Trastuzumab Deruxtecan
10.3390/cancers17183063 · 2025 · External reference
CT‐Based Body Composition and Nutritional Status as Predictors of Early‐Treatment Chemotherapy‐Related Infections and Hematologic Toxicity in Pediatric Cancer: A Prospective Study
10.1007/s00431-026-06882-x · 2026 · External reference
"What Matters to You?" Patient‐Reported Treatment Goals in Geriatric Oncology: A Cross‐Sectional Survey
10.1016/j.jgo.2023.101641 · 2024 · External reference
Impact of Sarcopenia on Prognosis, Treatment Toxicity and Surgical Complications in Locally Advanced Gastric Cancer
10.3390/cancers18091430 · 2026 · External reference
Post‐Chemotherapy Changes and Agreement of CT‐Derived Body Composition at L3 and T12 in Older Patients With Metastatic Colorectal Cancer: Associations With Nutritional Indices and Outcomes
10.3390/nu18071090 · 2026 · External reference
Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric Oncology
10.1200/jco.2018.78.8687 · 2018 · External reference
